Preterm Labor Clinical Trial
Official title:
Use of Pessary in Case of Cervical Insufficiency and Short Cervix
Prematurity is the most important cause of obstetric morbidity and mortality. Health centers
and obstetricians are trying to reduce the preterm birth rate by taking into account the
permanent effects of premature birth on human life in the early and long term.
The most effective solution of preterm delivery is to determine the patients entering the
risk group and to prevent preterm labor by putting the correct diagnosis at the right time.
Recently, there have been studies on the efficacy of pessary practice in preventing preterm
birth, but with the positive results of these studies, there has been hope for early birth
prevention as well as other treatments.
The aim of this study is; To assess the effectiveness of pessary use in patients with high
risk for preterm labor and prophylactic cervical length less than 25 mm below 25 weeks and
with a history of cervical insufficiency.
The aim of this study is; To assess the effectiveness of pessary use in patients with high
risk for preterm labor and prophylactic cervical length less than 25 mm below 25 weeks and
with a history of cervical insufficiency.
100 pregnant women with a preterm delivery history and / or a cervical length of less than
25 mm will be included among the pregnancies between 16 and 24 weeks of gestation referred
to obstetric and perinatology clinics. Information will be given about the success of
treatment in the prevention of early birth of the pessary and the use of the disease
pessary. Urine culture and cervical culture samples will be taken from both groups of
patients. In the presence of infection, the patient's treatment will be planned and out of
work. If no infection is detected and the patient agrees to use the pessary, the pessary
will be used to prevent premature birth.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06168149 -
The Relationship of Fetal Lung Elastography Values With the Development of Respiratory Distress in Cases of Preterm Labor
|
||
| Completed |
NCT02538718 -
Efficacy and Safety of MgSO4 as Tocolytics Compared to Ritodrine in Preterm Labor
|
N/A | |
| Not yet recruiting |
NCT05864066 -
Cyclin-dependent Kinase Inhibitor 2A (Placental Senescence Marker) on Labor-related Signals
|
||
| Terminated |
NCT03715530 -
Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women
|
N/A | |
| Recruiting |
NCT03638037 -
Correlation Between Maternal Vitamin D Level And Preterm Birth
|
||
| Recruiting |
NCT03992534 -
The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth
|
Phase 1 | |
| Withdrawn |
NCT03122704 -
Group B Streptococcus (GBS) Infection and in Preterm Labor Women Conceived Through IVF
|
N/A | |
| Completed |
NCT02536352 -
Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being
|
Early Phase 1 | |
| Recruiting |
NCT01518816 -
Role of Serum Total Antioxidant Level in Preterm Labor
|
N/A | |
| Recruiting |
NCT04590677 -
Prediction of the Onset of Term and Preterm Labour
|
||
| Completed |
NCT03112018 -
Strengthening Facility-based Intrapartum/Immediate Newborn Care to Reduce Mortality of Preterm Infants in Migori County, Kenya and Busoga Region, Uganda
|
N/A | |
| Active, not recruiting |
NCT04301518 -
Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs
|
N/A | |
| Completed |
NCT03785795 -
Multichannel EMG Diagnosing True Preterm Labor
|
||
| Withdrawn |
NCT02351310 -
Effectiveness of ACS in Extreme Preemies
|
Phase 3 | |
| Not yet recruiting |
NCT01985594 -
Utrogestan Versus Nifedipine as Tocolysis for Preterm Labor: a Randomised Controlled Trial
|
Phase 2 | |
| Not yet recruiting |
NCT04532086 -
Uterocervical Angle and Preterm Labour
|
||
| Completed |
NCT04605172 -
Lockdown Impact on Spontaneous Premature Birth in a Level III NICU
|
||
| Recruiting |
NCT04417595 -
Investigating N-3 Fatty Acids to Prevent Neonatal Tobacco-related outcomeS
|
Phase 2 | |
| Completed |
NCT03923023 -
Impact of the PREEMI Package on Neonatal Mortality
|
||
| Recruiting |
NCT06157203 -
Labor Status Monitor for Diagnosing True vs False Labor in Preterm Patients
|